Nipah Virus Vaccine Testing: Big news is coming regarding Nipah virus vaccine. Oxford University has started human testing of Nipah Virus vaccine, which is causing concern in some states of India including Kerala and many parts of Asia. There is currently no vaccine available for this virus. In its trial, technology similar to the Covid-19 shots of AstraZeneca and Serum Institute of India is being used. Let us tell you that Nipah virus was first identified in Malaysia about 25 years ago. After this, its impact was seen in Bangladesh, India and Singapore.
How is human testing of Nipah virus being done?
A spokesperson for Oxford University’s Institute of Epidemiology told news agency Reuters that the first phase of testing in Oxford with 52 participants will assess safety and immune response in people aged 18 to 55 years. The first participants in the Oxford testing received a dose of the vaccine last week. This shot is based on the same technology that was used in the Covid-19 (Covid 19) shots of AstraZeneca (AZN.L) and Serum Institute of India.
What did Oxford say about vaccine testing?
Dr. In Kyu Yoon said that there is a possibility of Nipah epidemic, its fruit bats are found in areas where the population is more than two billion. This means that more people live in these areas. This trial is a step forward in trying to create a suite of tools to protect against this deadly virus. Oxford Vaccine Group is doing this testing, for which CEPI is funding. It is a global organization that helps in creating vaccines to fight infectious diseases. In 2022, Nipah virus vaccine was tested with the help of the US National Institute of Allergy and Infectious Diseases. Now the countries affected by this virus are hopeful of the arrival of the vaccine soon.
Read also
Check out below Health Tools-
Calculate Your Body Mass Index (BMI)